RESEARCH AND DEVELOPMENT
Hong Kong Yuanhua Biotechnology on-going commitment to Research and Development (R&D) is the foundation for our company to remain a strategic driver in the advancement of the progress of targeted drug delivery technology. All of our R&D programs aim to deliver highly innovative cancer therapies that currently have few, if any, effective treatment options.
Hong Kong Yuanhua Biotechnology team of world-class R&D scientists never settle for incremental benefits. Rather, we strive to completely change the landscape of disease and strive to pursue diseases in any therapeutic area with whatever modality we can.
Our R&D strategy serves to align and engage our talent, prioritize our investments and seize scientific opportunities, and is based around the following key components:
• Focus on innovative medicines for unmet needs in patients with serious illnesses;
• Maintain an expansive toolkit of drug modalities with a focus on biologics;
• Focus on return on investment and operational efficiency;
• Harness external innovation, and;
• Demonstrate the value of our medicines.